MedPath

丽珠集团利民制药厂

Ownership
-
Established
1997-05-24
Employees
-
Market Cap
-
Website
zyzjs.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

157

NMPA:157

Drug Approvals

Progesterone Injection(II)

Product Name
黄体酮注射液(Ⅱ)
Approval Number
国药准字H20253626
Approval Date
Mar 18, 2025
NMPA

血栓通注射液

Approval Number
国药准字Z44020284
Approval Date
Mar 15, 2024
NMPA

血栓通注射液

Approval Number
国药准字Z44020285
Approval Date
Mar 15, 2024
NMPA

参芪扶正注射液

Approval Number
国药准字Z19990065
Approval Date
Mar 15, 2024
NMPA

复方五指柑胶囊

Approval Number
国药准字Z20130017
Approval Date
Aug 26, 2022
NMPA

Dextran 40 and Amino Acids Injection

Product Name
右旋糖酐40氨基酸注射液
Approval Number
国药准字H44025314
Approval Date
Nov 1, 2021
NMPA

复方乌槟颗粒

Approval Number
国药准字Z20070038
Approval Date
Aug 26, 2021
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H44022656
Approval Date
Sep 28, 2020
NMPA

Dextran 40 Sodium Chloride Injection

Product Name
右旋糖酐40氯化钠注射液
Approval Number
国药准字H44023015
Approval Date
Sep 27, 2020
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H44024897
Approval Date
Sep 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.